Pulmonary Arterial Hypertension | Registry for Pulmonary Hypertension in China
Pulmonary Arterial Hypertension research study
What is the primary objective of this study?
1. To characterize the demographics and clinical course of the patient population diagnosed as having WHO group I pulmonary arterial hypertension and WHO group IV pulmonary hypertension due to chronic thromboembolic pulmonary hypertension 2. To describe real-world outcome of Chinese patients with WHO group I pulmonary arterial hypertension and WHO group IV pulmonary hypertension due to chronic thromboembolic pulmonary hypertension 3. To evaluate differences in patient outcomes according to classification subgroup 4. To identify clinical predictors of long-term survival 5. To assess the relationship between targeted therapies for pulmonary arterial hypertension and patient outcomes
Who is eligible to participate?
Inclusion Criteria: - Signed patients'consent - Diagnosed by right heart catheterization one month within study enrollment - patients who were firstly diagnosed as pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension Exclusion Criteria: - Not meeting inclusion criteria
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Pulmonary Arterial Hypertension
Chronic Thromboembolic Pulmonary Hypertension
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Pulmonary hypertension groupPatients who were firstly diagnosed as pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Start Date: August 2009
Completed Date: December 2020
Primary Outcome: Survival
Study sponsors, principal investigator, and references
Principal Investigator: Jian-Guo He, M.D.
Lead Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon MD. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010 Feb;137(2):376-87. doi: 10.1378/chest.09-1140. Epub 2009 Oct 16.